Safety and efficacy of rivastigmine and memantine combined for treatment of patients with Alzheimer’s disease: a retrospective study
American Journal of Translational Research · 2025 · 17 (3) · 2240-2249
DOI: 10.62347/yopp4162 ↗At a glance
Journal article in American Journal of Translational Research, 2025. Written by Haiyan Wang and 1 co-authors. Institution: Department of Geriatric Psychiatry, The Third People's Hospital of Yongkang No. 18 Feifeng Road, Xicheng Street, Yongkang City, Jinhua 321300, Zhejia…. Cited 4 times so far (Crossref); 35 references. The full text is freely available in PubMed Central.
Topics: Demenz
Abstract (original language)
OBJECTIVE: To assess the effects and safety of combining rivastigmine hydrogen tartrate capsules with memantine tablets for Alzheimer's disease (AD). METHODS: A retrospective study was conducted on AD patients admitted to The Third People's Hospital of Yongkang from November 2021 to June 2023. There were two groups: a single drug group (n=21) given only memantine tablets, and a combination group (n=39) treated with both rivastigmine hydrogen tartrate capsules and memantine tablets. Data were collected, including age, gender, education, overall response rate, adverse reaction rate, mini-mental state examination (MMSE), activity of daily living (ADL), behavioral pathology in Alzheimer's disease scale (BEHAVE-AD), serum tumor necrosis factor-α (TNF-α), serum interleukin-6 (IL-6) and serum Tau at baseline and at week 12. RESULTS: In both groups, compared to baseline, at week 12, MMSE increased, while ADL, BEHAVE-AD, serum TNF-α, IL-6, and Tau decreased (all P
Subjects
Author keywords
Authors and institutions
- Department of Geriatric Psychiatry, The Third People's Hospital of Yongkang No. 18 Feifeng Road, Xicheng Street, Yongkang City, Jinhua 321300, Zhejiang, China.
Cite
APA
Wang, H., & Lv, P. (2025). Safety and efficacy of rivastigmine and memantine combined for treatment of patients with Alzheimer’s disease: a retrospective study. American Journal of Translational Research, 17(3), 2240-2249. https://doi.org/10.62347/yopp4162
Vancouver
Wang H, Lv P. Safety and efficacy of rivastigmine and memantine combined for treatment of patients with Alzheimer’s disease: a retrospective study. American Journal of Translational Research. 2025;17(3):2240-2249. doi:10.62347/yopp4162
BibTeX
@article{Wang2025,
author = {Wang, Haiyan and Lv, Pingping},
title = {Safety and efficacy of rivastigmine and memantine combined for treatment of patients with Alzheimer’s disease: a retrospective study},
journal = {American Journal of Translational Research},
year = {2025},
volume = {17},
number = {3},
pages = {2240--2249},
doi = {10.62347/yopp4162}
}
EUVIMED